Pharming Group N.V. — Short Positions & Disclosures
Regulatory net short position disclosures over time
As of 16 Apr 2026, 4 institutions have disclosed net short positions in Pharming Group N.V. totalling 3.03% of issued share capital. The largest disclosed short seller is Lazard Asset Management LLC at 1.18%. Positions are publicly disclosed under UK FCA rules once they reach or exceed 0.5% of issued share capital.
Last updated
Pharming Group N.V. | Short Positions Over Time
NL0010391025Short positions must be disclosed when they reach or exceed 0.5% of issued share capital.
Current Short Positions
All disclosed positions as of the latest report date
| Holder | Net Short % | Position Date | Position Value |
|---|---|---|---|
Lazard Asset Management LLC | 1.18% | 16 Apr 2026 | €11.7m |
D. E. Shaw & Co., L.P. | 0.59% | 27 Mar 2026 | €5.8m |
Capstone Volatility Master (Cayman) Limited | 0.66% | 02 Feb 2026 | €6.5m |
Whitebox Advisors LLC | 0.60% | 01 Oct 2025 | €5.9m |
Data source: UK Financial Conduct Authority short position disclosures, plus equivalent disclosures from EU regulators (BaFin, CONSOB, AFM, Finansinspektionen). View FCA short selling rules.
Net short percentage represents the percentage of issued share capital held short. Positions must be publicly disclosed when they reach or exceed the 0.5% regulatory threshold. Read the methodology.